Cargando…

Construction of Immunoradiometric Assay for Circulating c‐erbB‐2 Protooncogene Product in Advanced Breast Cancer Patients

The human c‐erbB‐2 protooncogene product (erbB‐2 protein) is a 185 kilodalton glycoprotein closely related to epidermal growth factor receptor protein. In this study, we measured the concentration of circulating erbB‐2 protein in cancer patients by means of a new immunoradiometric assay (IRMA). Two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosono, Makoto, Saga, Tsuneo, Sakahara, Harumi, Kobayashi, Hisataka, Shirato, Makoto, Endo, Keigo, Yamamoto, Tadashi, Akiyama, Tetsu, Toyoshima, Kumao, Konishi, Junji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1993
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919131/ https://www.ncbi.nlm.nih.gov/pubmed/8096502 http://dx.doi.org/10.1111/j.1349-7006.1993.tb02848.x

Ejemplares similares

A Murine Monoclonal Antibody that Recognizes an Extracellular Domain of the Human c‐erbB‐2 Protooncogene Product
por: Masuko, Takashi, et al.
Publicado: (1989)

Effect of Circulating Antigen on Immunoscintigraphy of Ovarian Cancer Patients Using Anti‐CA125 Monoclonal Antibody
por: Sakahara, Harumi, et al.
Publicado: (1996)

In vitro and in vivo Release of Soluble erbB‐2 Protein from Human Carcinoma Cells
por: Mori, Shigeo, et al.
Publicado: (1990)

Comparison of the Chase Effects of Avidin, Streptavidin, Neutravidin, and Avidin‐Ferritin on a Radiolabeled Biotinylated Anti‐tumor Monoclonal Antibody
por: Kobayashi, Hisataka, et al.
Publicado: (1995)

An Antibody‐Tumor Model for the Targeting of CA125‐producing Gynecologic Malignancies
por: Saga, Tsuneo, et al.
Publicado: (1990)

Influence of Cocktails of Labeled Monoclonal Antibodies on the Localization of Antibodies in Human Tumor Xenografts
por: Watanabe, Yuji, et al.
Publicado: (1990)

Association of Elevated Expression of the c‐erbB‐2 Protein with Spread of Breast Cancer
por: Yamada, Yukinori, et al.
Publicado: (1989)

Expression and Characterization of Kinase‐active v‐erbB Protein Using a Baculovirus Vector System
por: Morishita, Kaoru, et al.
Publicado: (1992)

Avidin Chase Can Reduce Myelotoxicity Associated with Radioimmunotherapy of Experimental Liver Micrometastases in Mice
por: Sato, Noriko, et al.
Publicado: (2000)

Radioimmunotherapy for Liver Micrometastases in Mice: Pharmacokinetics, Dose Estimation, and Long‐term Effect
por: Saga, Tsuneo, et al.
Publicado: (1999)

Immunoscintigraphy and Pharmacokinetics of Indium‐111‐labeled ZME‐018 Monoclonal Antibody in Patients with Malignant Melanoma
por: Koizumi, Mitsuru, et al.
Publicado: (1988)

Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies.
por: Sakahara, H., et al.
Publicado: (1993)

Anti‐murine Antibody Response to Mouse Monoclonal Antibodies in Cancer Patients
por: Sakahara, Harumi, et al.
Publicado: (1997)

Immunohistochemical Study on Overexpression of c‐erbB‐2 Protein in Human Breast Cancer: Its Correlation with Gene Amplification and Long‐term Survival of Patients
por: Tsuda, Hitoshi, et al.
Publicado: (1990)

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)

Detection of Homing, Proliferation, and Infiltration Sites of Adult T Cell Leukemia Cells in Severe Combined Immunodeficiency Mice Using Radiometric Techniques
por: Takaori‐Kondo, Akifumi, et al.
Publicado: (1995)

Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011)

Mutational Screening in Tyrosine-Kinase Domain of erbB1 And erbB2 Genes
por: ALONSO, Juan Manuel Fernández
Publicado: (2005)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017)

Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
por: Børresen, A. L., et al.
Publicado: (1990)

Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
por: Yao, Yong-Liang, et al.
Publicado: (2013)

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.
por: Aasland, R., et al.
Publicado: (1988)

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2018)

Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2016)

A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
por: Meng, Y, et al.
Publicado: (2016)

Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer
por: Mitsui, Keigo, et al.
Publicado: (2014)

The Role of ErbB Receptors in Infection
por: Ho, Jemima, et al.
Publicado: (2017)

FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
por: Benlimame, Naciba, et al.
Publicado: (2005)

ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
por: Moghbeli, Meysam, et al.
Publicado: (2019)

Detection of Altered Adhesion Molecule Expression in Experimental Tumors by a Radiolabeled Monoclonal Antibody
por: Saga, Tsuneo, et al.
Publicado: (1997)

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
por: Colomer, R., et al.
Publicado: (1994)

Betacellulin-Induced Beta Cell Proliferation and Regeneration Is Mediated by Activation of ErbB-1 and ErbB-2 Receptors
por: Oh, Yoon Sin, et al.
Publicado: (2011)

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
por: Singer, Josef, et al.
Publicado: (2012)

Quantitative Analysis of ErbB1 and ErbB2 Genes Amplification by a High Performance Liquid Chromatography
por: Rasti, Mozhgan, et al.
Publicado: (2014)

Effects of ErbB2 Overexpression on the Proteome and ErbB Ligand-specific Phosphosignaling in Mammary Luminal Epithelial Cells
por: Worthington, Jenny, et al.
Publicado: (2017)

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
por: Ueno, Sho, et al.
Publicado: (2020)

DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells
por: Bi, Yanli, et al.
Publicado: (2021)

The interactome of human EGF/ErbB receptors
por: Uetz, Peter, et al.
Publicado: (2006)

The c-MYC Protooncogene Expression in Cholesteatoma
por: Palkó, Enikő, et al.
Publicado: (2014)

Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins
por: Hutcheson, IR, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0it135si2c2oipqjklu8771u8b